The aim of the presented study was to determine SCL, OPG, and RANK-L concentrations in patients with acromegaly with regard to the disease activity and to evaluate the association between sclerostin concentrations and OPG/RANK-L system, GH, IGF-1, and BMD. The gene discussed is TNFSF11; the disease is acromegaly.